Testicular plasmacytomas are rare, accounting for only 1.3% of all extramedullary plasmacytomas. The infrequency in which it is encountered, coupled with its non-specific clinical and sonographic presentation, makes its diagnosis a challenge. We present a case of a 70-year-old man with multiple myeloma, which was systemically responding to chemotherapy, who developed testicular swelling, erythema and pain. Ultrasound findings were concerning for infection, although urine and serum testing were unremarkable. The patient did not improve after several rounds of antibiotics prompting further evaluation. The patient underwent radical orchiectomy which revealed testicular plasmacytoma. Fluorescent in situ hybridisation (FISH) of the testicular tissue noted mutations which had not been present in the FISH analysis of bone marrow. Positron emission tomography scan later revealed new retroperitoneal plasmacytomas involving the new clone and his chemotherapy regimen needed to be adjusted for treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990111 | PMC |
| http://dx.doi.org/10.1136/bcr-2017-222046 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Solitary Testicular Plasmacytoma: A Case Report.
Urol Int
December 2024
Department of Urology, Misugikai Otokoyama Hospital, Kyoto, Japan.
Article Synopsis
- Plasmacytoma of the testis is a rare type of cancer that can appear as a solitary tumor or alongside multiple myeloma, with a generally good prognosis from localized treatments like surgery or radiation.
- A case of a 69-year-old man with a solitary testicular plasmacytoma showed that initial treatment was successful, but he later developed bone lesions, leading to the need for chemotherapy.
- The findings suggest that while STP is rare and its prognosis can be unclear, systemic chemotherapy may be necessary for recurrence, emphasizing the importance of long-term patient follow-up.
Relapsed IgA Multiple Myeloma as Testicular Plasmacytoma after Quadrable Novel Therapy and Autologous Stem Cell Transplant: A Rare Case Report and Literature Review.
Case Rep Oncol
February 2024
Division of Hematology, Department of Medical Oncology, National Centre for Cancer Care and Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar.
Introduction: Multiple myeloma (MM) is a clonal neoplasm of plasma cells that may manifest as an extramedullary disease in rare cases.
Case Report: In this case report, we present the rare occurrence of testicular relapse in a 39-year-old patient with IgA MM after 3 years of remission. We discuss the clinical course and management of this unusual presentation and provide a comprehensive literature review of testicular involvement by MM.
[Onset of Testicular Plasmacytoma in a Patient with Refractory Multiple Myeloma].
Gan To Kagaku Ryoho
December 2023
Dept. of Hematology, Osaka General Hospital of West Japan Railway Company.
Article Synopsis
- A 72-year-old man undergoing chemotherapy for multiple myeloma experienced testicular swelling 3 years after diagnosis.
- Following a high orchiectomy, he was diagnosed with plasmacytoma, prompting treatment with isatuximab and dexamethasone.
- Current follow-up shows no recurrence, highlighting the importance of pathological evaluation for accurate diagnosis and treatment in rare testicular tumors.
A Case of Recurrent Multiple Myeloma as Testicular Plasmacytoma Without Systemic Disease.
Cureus
June 2023
Pathology, Advocate Lutheran General Hospital, Park Ridge, USA.
Plasma cell neoplasms include various conditions ranging from indolent conditions such as monoclonal gammopathy of undetermined significance (MGUS) to more aggressive forms such as multiple myeloma (MM). The World Health Organization classifies plasmacytomas into two types: solitary osseous plasmacytoma (SOP) and extramedullary plasmacytoma (EMP). Most primary EMPs occur in the upper gastrointestinal tract, head and neck, upper respiratory system, central nervous system, lungs, liver, spleen, and kidneys.
View Article and Find Full Text PDFTesticular Plasmacytoma Masking as Epididymo-orchitis in a Known Multiple Myeloma Patient.
Cancer Diagn Progn
September 2022
Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA, U.S.A.
Background/aim: Extramedullary plasmacytoma (EMP) is defined as a localized plasma cell neoplasm that arises in tissues other than the bone. The most common sites of involvement of EMP are the upper airways followed by lymph nodes, gastrointestinal tract, thyroid gland, skin, brain, liver, and lungs. Testicular plasmacytoma has a very rare occurrence with about 70 cases reported in literature to date.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!